Salmonella enterica serotype paratyphi-A has been reported less frequently as a causative agent of enteric fever. Reports on the antimicrobial susceptibility of this pathogen are few and varied. An unusual high occurence of Salmonella paratyphi-A was noted in our study carried out at pathology department, Army Medical College, Rawalpindi. Blood cultures of patients suspected to have enteric fever were processed by conventional methods. Antimicrobial susceptibility was tested by Kirby-Bauer disc diffusion method and minimum inhibitory concentration (MIC) to ciprofloxacin, ofloxacin and nalidixic acid was determined by E-test (AB-Biodisc, Sweden). Results were interpreted according to NCCLS (National Committee for Control Laboratory Standard) recommendations. Statistical analysis was done by SPSS 10.0 for windows (Statistical Package for Social Sciences). Out of 100 typhoid 59(59%) salmonellae were Salmonella enterica serotype paratyphi-A and all were sensitive to ciprofloxacin, ofloxacin and nalidixic acid except one isolate which showed resistance to nalidixic acid both on disc diffusion and MIC determination. 37 isolates (62.7%) were resistant to first line antibiotics (ampicillin, chloramphenicol an dco-trimoxazole) on disc diffusion testing. A high occurrence of Salmonella enterica serotype paratyphi-A found in the present study indicated the emergence of this rare pathogen of enteric fever in local population. Development of multidrug resistant Salmonella enterica serotype paratyphi-A indicates the need for continued surveillance and monitoring of antimicrobial susceptibility susceptibility of these isolates.